Cargando…
Tripterygium wilfordii derivative LLDT-8 targets CD2 in the treatment of rheumatoid arthritis
Rheumatoid arthritis (RA), a chronic inflammatory synovitis systemic disease, can lead to joint deformities, loss of function and even death. The pathogenesis of RA may be related to genetics, infection and/or sex hormones; however, detailed accounts of the molecular mechanisms underlying its pathog...
Autores principales: | Li, Yuan, Qi, Wufang, Yan, Lei, Wang, Mengmeng, Zhao, Linru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372124/ https://www.ncbi.nlm.nih.gov/pubmed/34429967 http://dx.doi.org/10.3892/br.2021.1457 |
Ejemplares similares
-
Clinical Practice Guideline for Tripterygium Glycosides/Tripterygium wilfordii Tablets in the Treatment of Rheumatoid Arthritis
por: Lin, Na, et al.
Publicado: (2021) -
Tripterygium wilfordii Hook. f. Preparations for Rheumatoid Arthritis: An Overview of Systematic Reviews
por: Li, Huimin, et al.
Publicado: (2022) -
Bibliometric analysis of trends in research of Tripterygium wilfordii Hook F for treating rheumatoid arthritis
por: Li, Wenyuan, et al.
Publicado: (2023) -
A Network Pharmacology Study on the Active Ingredients and Potential Targets of Tripterygium wilfordii Hook for Treatment of Rheumatoid Arthritis
por: Hu, Wei, et al.
Publicado: (2019) -
The Derivative of Tripterygium wilfordii Hook F—Kunxian Capsule, Attenuated Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Liu, Ya-Fei, et al.
Publicado: (2020)